메뉴 건너뛰기




Volumn 26, Issue 5, 2006, Pages 544-545

Lack of effect of chromium supplementation on mental state and body weight in people with schizophrenia [9]

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHROMIUM PICOLINATE; HEMOGLOBIN A1C; NEUROLEPTIC AGENT;

EID: 33748750226     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000236587.40340.49     Document Type: Letter
Times cited : (4)

References (8)
  • 1
    • 0029792285 scopus 로고    scopus 로고
    • A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase
    • Davis CM, Sumrall KH, Vincent JB. A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase. Biochemistry. 1996;35:12963-12969.
    • (1996) Biochemistry , vol.35 , pp. 12963-12969
    • Davis, C.M.1    Sumrall, K.H.2    Vincent, J.B.3
  • 2
    • 7744226273 scopus 로고    scopus 로고
    • Common dietary supplements for weight loss
    • Saper R, Eisenberg D, Philips R. Common dietary supplements for weight loss. Am Fam Physician. 2004;70:1731-1738.
    • (2004) Am Fam Physician , vol.70 , pp. 1731-1738
    • Saper, R.1    Eisenberg, D.2    Philips, R.3
  • 3
    • 0037304640 scopus 로고    scopus 로고
    • Effectiveness of chromium in atypical depression: A placebo-controlled trial
    • Davidson JRT, Abraham K, Connor KM, et al. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiatry. 2003;3:261-264.
    • (2003) Biol Psychiatry , vol.3 , pp. 261-264
    • Davidson, J.R.T.1    Abraham, K.2    Connor, K.M.3
  • 4
    • 0036171368 scopus 로고    scopus 로고
    • Chromium treatment decreases the sensitivity of 5-HT2A receptors
    • Attenburrow M-J, Odontiadis J, Murray BJ, et al. Chromium treatment decreases the sensitivity of 5-HT2A receptors. Psychopharmacology. 2002;159:432-436.
    • (2002) Psychopharmacology , vol.159 , pp. 432-436
    • Attenburrow, M.-J.1    Odontiadis, J.2    Murray, B.J.3
  • 5
    • 17444405568 scopus 로고    scopus 로고
    • Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: A cross-sectional study
    • Mackin P, Watkinson HM, Young AH. Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study. Diabetologia. 2005;48:215-221.
    • (2005) Diabetologia , vol.48 , pp. 215-221
    • Mackin, P.1    Watkinson, H.M.2    Young, A.H.3
  • 6
    • 0036297793 scopus 로고    scopus 로고
    • Glucose and insulin responses to dietary chromium supplements: A meta-analysis
    • Althuis MD, Jordan NE, Ludington EA, et al. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr. 2002;76:148-155.
    • (2002) Am J Clin Nutr , vol.76 , pp. 148-155
    • Althuis, M.D.1    Jordan, N.E.2    Ludington, E.A.3
  • 7
    • 19944424137 scopus 로고    scopus 로고
    • Complementary therapies for diabetes: The case for chromium, magnesium, and antioxidants
    • Guerro-Romero F, Rodriguez-Moran M. Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch Med Res. 2004;36:250-257.
    • (2004) Arch Med Res , vol.36 , pp. 250-257
    • Guerro-Romero, F.1    Rodriguez-Moran, M.2
  • 8
    • 0030695031 scopus 로고    scopus 로고
    • Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes
    • Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46:1786-1791.
    • (1997) Diabetes , vol.46 , pp. 1786-1791
    • Anderson, R.A.1    Cheng, N.2    Bryden, N.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.